Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-415
HR+
Luminal
17-AAG
HSP90
HSP90
9664.037
uM
0.09572
0.11439
-0.9995 -0.7190 5.0000 0.8937
0.9660
0.7953
MDA-MB-361
HER2amp
Luminal
Valproic acid
HDAC
HDAC
12379.143
uM
450.79670
972.52820
-0.9995 -1.0000 1.4288 0.4119
0.9965
0.4493
600MPE
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5899.067
uM
2.37830
4.93120
-0.9995 -1.0000 1.5066 0.6079
0.9889
0.9897
HCC202
HER2amp
Luminal
Trichostatin A
HDAC
HDAC
7458.065
uM
0.92043
1.63230
-0.9995 -1.0000 1.9177 1.2766
0.9965
0.4917
HCC1395
TNBC
Basal B
Methylglyoxal
13165.184
uM
488.01040
1000.00000
-0.9995 -0.7261 1.2503 0.4988
0.9358
0.5940
LY2
HR+
Luminal
Trichostatin A
HDAC
HDAC
7477.065
uM
6.29540
8.97720
-0.9995 -0.9667 3.0326 0.9357
0.9982
0.7891
BT-483
HR+
Luminal
Temsirolimus
MTOR
MTOR
11855.144
uM
0.00173
0.54075
-0.9995 -1.0000 0.1912 0.9073
0.6959
0.5961
MDA-MB-361
HER2amp
Luminal
Doxorubicin
TOP2
TOP
9648.121
uM
0.11428
0.13646
-0.9995 -0.7141 5.0000 0.8762
0.9561
0.6537
MDA-MB-361
HER2amp
Luminal
Epirubicin
TOP2
TOP
7896.017
uM
0.25479
0.30463
-0.9995 -0.7217 5.0000 0.8046
0.9647
1.0113
UACC-812
HER2amp
Luminal
Afatinib
EGFR/HER2
ErbB
11938.158
uM
0.00298
0.02730
-0.9995 -1.0000 0.4957 1.2060
0.9673
0.5846
LY2
HR+
Luminal
Vorinostat
HDAC
HDAC
7477.065
uM
164.46940
242.89610
-0.9995 -0.9975 2.8133 0.6664
0.9940
0.7891
600MPE
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
5898.091
uM
24.51260
30.53630
-0.9995 -1.0000 4.9997 0.4350
0.9907
0.6159
HCC1395
TNBC
Basal B
GSK461364
PLK1
PLK
7813.001
uM
0.01050
0.01379
-0.9995 -0.5491 2.7174 0.8875
0.9467
0.7338
MDA-MB-361
HER2amp
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7508.067
uM
9.14220
11.38870
-0.9994 -1.0000 5.0000 0.4106
0.9941
0.7560
MDA-MB-175-VII
HR+
Luminal
ZM-447439
AURK
AURK
10642.138
uM
19.16960
29.1850
-0.9994 -1.0000 2.6137 0.4105
0.7449
0.5620
MX1
Unknown
Unknown
Bortezomib
Proteasome
Proteasome
14918.203
uM
0.00872
0.01466
-0.9994 -0.9980 2.1115 1.3233
0.9984
0.5296
SUM1315MO2
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
9044.074
uM
0.03803
0.06612
-0.9994 -0.9731 1.9532 1.1764
0.9971
0.6607
HCC38
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
10268.12
uM
0.00161
0.00201
-0.9994 -1.0000 5.0000 1.6132
0.9985
0.3272
MX1
Unknown
Unknown
Bortezomib
Proteasome
Proteasome
14918.203
uM
0.00872
0.01466
-0.9994 -0.9980 2.1115 1.3233
0.9984
0.5296
BT-474
HER2amp
Luminal
GSK461364
PLK1
PLK
9163.001
uM
inf
inf
-0.9994 -0.9994 0.0000 0.4623
0.5005
0.5227
BT-474
HER2amp
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12178.154
uM
0.27381
1.07140
-0.9994 -1.0000 0.8053 0.5291
0.9912
0.5170
HCC1428
HR+
Luminal
Epirubicin
TOP2
TOP
9294.017
uM
1.25510
1.74180
-0.9994 -0.9690 3.2891 0.6721
0.9982
0.8160
UACC-812
HER2amp
Luminal
IKK16
IKK
NFKB
10420.093
uM
4.17050
5.19540
-0.9994 -1.0000 5.0000 0.4914
0.9287
0.5629
UACC-812
HER2amp
Luminal
CGC-11047
Polyamine analogue
10267.026
uM
15.170
207.56150
-0.9994 -1.0000 0.4199 0.5813
0.7864
0.3125
SUM52PE
HR+
Luminal
CGC-11047
Polyamine analogue
7923.018
uM
0.15750
6.39610
-0.9994 -1.0000 0.2966 1.0403
0.7812
0.7947